The past ten years have proven challenging for the pharma industry, witnessing a large number of mergers and acquisitions within it. Recently, this tendency has been reinforced with what may be called super mergers and acquisitions. It is obvious that the financial reality, marked by an economic deceleration and credit compression, is behind this, but it is not the only important factor.
Read More...
[Source: Business Articles from EzineArticles.com - Posted by FreeAutoBlogger]